查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1862966

體外診斷包裝市場：依包裝類型、材料、最終用戶、無菌條件、溫度需求和分銷管道分類－2025-2032年全球預測

In-Vitro Diagnostics Packaging Market by Packaging Format, Material, End User, Sterility, Temperature Requirement, Distribution Channel - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，體外診斷包裝材料市場將成長至 132.5 億美元，複合年成長率為 7.01%。

主要市場統計數據
基準年 2024 77億美元
預計年份：2025年 82.4億美元
預測年份：2032年 132.5億美元
複合年成長率 (%) 7.01%

以完整性、可追溯性和永續性為策略導向，診斷包裝正在重塑其支持臨床工作流程和監管期望的方式。

體外診斷包裝產業正經歷一場變革，其驅動力包括加速創新、加強監管以及對供應鏈韌性的重視。包裝不再僅僅提供容納和保護，而是成為支撐檢體生命週期內診斷準確性、生物安全性和可追溯性的基石。隨著實驗室、醫院、照護現場機構和研究機構不斷拓展檢測方法，對包裝解決方案的需求也迅速多元化。這種變革迫使製造商和採購團隊重新思考材料選擇、無菌處理以及端到端低溫運輸能力，以維持檢體完整性並確保患者安全。

整合製造、尖端材料和數位化可追溯性的融合，正在重新定義包裝在診斷準確性、物流和採購管道中的作用

產業正經歷變革時期，重塑競爭格局和營運重點。無菌加工技術的進步，例如吹灌封系統和整合式盒式生產，在提高產量的同時降低了污染風險。軟性包裝的創新正在最佳化運輸重量和儲存效率。這些工藝層面的創新與材料科學的突破相輔相成。特殊聚合物和配方穩定層壓材料提高了阻隔性能和耐熱性，從而拓展了產品在常溫、冷藏和冷凍等不同溫度環境下的應用範圍。因此，包裝正從被動的保護者轉變為診斷能力和物流效率的積極推動者。

關稅調整和貿易政策變化促使供應鏈重組和區域化生產投資，以保障診斷包裝的連續性和合規性。

2025年實施的關稅和貿易政策調整對原料和成品診斷包裝材料的整體進口造成了顯著壓力，促使生產商和採購商迅速採取戰略性應對措施。關稅導致的成本增加加速了對供應商所在地和合約條款的重新評估，尤其是那些來自全球供應鏈的組件和基材。在這種環境下，尋找替代原料、繪製供應鏈圖以及評估供應商風險變得更加緊迫，這些措施既要保證屏障性能和無菌性，又要確保符合監管要求。

按規格、材料、最終用戶、滅菌狀態、溫度和分銷管道進行細分，凸顯了診斷包裝中目標產品和市場推廣的重要性。

市場區隔揭示了不同的需求模式和技術要求，從而指南產品開發和商業化策略。包裝趨勢傾向於吹灌封式包裝（尤其是安瓿瓶、卡匣和盒式包裝），因為無菌性、精確劑量和整合填充至關重要；而薄膜和複合材料、軟包裝袋等軟性包裝則支援大容量試劑分發和輕便運輸。包括微孔盤載玻片和試管管瓶的硬質包裝仍然是實驗室自動化和檢體儲存的核心，其人體工學和儀器相容性也在不斷最佳化。

監管重點、生產能力和低溫運輸成熟度方面的區域差異，正在塑造診斷包裝採用方面不同的策略方法。

區域趨勢凸顯了影響製造地、監管策略和物流投資的多元化優先事項。在美洲，對先進實驗室基礎設施和照護現場部署的集中需求推動了無菌、自動化相容的硬質容器的廣泛應用，以及對冷藏和常溫解決方案的持續需求。該地區的監管環境和採購週期正在推動對國內或鄰近生產的投資，尤其是在政策變化導致進口成本上升或優先考慮供應安全的地區。

為了確保競爭優勢，各公司都在加強其無菌加工能力，推動材料創新和數位化可追溯性，並擴大其服務範圍和擴大本地生產。

診斷包裝領域的主要企業正採取多元化的競爭策略，將技術投資與業務重組結合。許多企業正在強化其無菌加工和吹灌封 (BFS) 系統的能力，以降低污染風險並提高無菌一次性產品的生產效率。同時，材料創新專案致力於研發特殊聚合物和複合材料結構，以改善阻隔性和熱穩定性，同時提高可回收性並減輕材料重量。此外，各企業也正在投資數位化工具，例如序列化、RFID 標籤和雲端追溯系統，以滿足客戶對監管鏈視覺性和合規性文件的需求。

考慮整合供應鏈多元化、區域產能擴張和數位化可追溯性，以增強診斷包裝領域的韌性、合規性和客戶協作。

產業領導者可以製定重點行動計劃，化挑戰為優勢。優先發展多元化的供應商網路，並對關鍵基材採取雙重採購模式，以確保材料間檢驗的等效性，同時降低受貿易政策變化和區域生產限制的影響。增加對本地無菌填充和二次包裝能力的投資，以縮短前置作業時間並降低關稅風險，並將這些投資與無菌​​檢驗計劃相結合，確保符合監管要求。將特種聚合物選項和檢驗的層壓結構納入產品系列，以滿足常溫、冷藏和冷凍應用場景下的隔熱和阻隔性需求，同時推動可衡量的永續永續性目標。

本研究採用嚴謹的混合方法研究途徑，結合相關人員訪談、技術評估和交叉檢驗的案例分析，旨在深入了解包裝技術及其應用。

我們的調查方法結合了第一手資料和第二手資料，旨在對診斷包裝行業的現狀進行實證分析。第一手資料包括對來自診斷實驗室、醫院診所、就地檢驗提供者和研究機構的包裝工程師、供應鏈經理、法規事務專業人員和採購人員進行結構化訪談，以收集營運重點和檢驗方法。第二手資料包括查閱法規指南、技術標準、專利趨勢、製造案例研究和科學文獻，以綜合分析材料在常溫、冷藏和冷凍運輸條件下的性能、無菌加工趨勢以及低溫運輸要求。

對無菌處理、材料認證和數位化可追溯性的協調投資對於確保診斷的完整性和營運的韌性至關重要。

製造創新、材料科學、不斷變化的法規以及貿易政策的協調一致，正在為體外診斷包裝創造一種新的營運模式。包裝正被視為一項策略性資產，它能夠保障診斷準確性、提升供應鏈彈性並支持永續性。那些將無菌處理能力、特殊材料和數位化可追溯性方面的投資與區域最佳化製造地相結合的企業，將更有能力應對關稅波動帶來的影響，並滿足診斷實驗室、醫院診所、就地檢驗機構和研究機構的複雜需求。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 體外診斷包裝中永續和可回收材料有助於滿足監管和環境要求。
  • 將RFID和NFC等智慧包裝技術整合到體外診斷試劑盒中，以增強可追溯性並提高患者安全性。
  • 開發用於照護現場體外診斷測試的密封式拋棄微流體晶片
  • 可客製化的低溫運輸包裝解決方案，採用相變材料以在運輸過程中維持生物標記的穩定性
  • 過渡到採用兒童安全防篡改包裝設計，以確保符合體外診斷產品的全球安全法規。
  • 診斷設備機殼上的抗菌塗層可降低污染風險並延長保存期限
  • 在體外診斷包裝中引入數位和可變數據印刷技術，實現批次特異性標籤和即時品管。
  • 輕質聚合物泡殼包裝：減輕包裝重量，減少高頻診斷測試的廢棄物
  • 使用符合 ISO 13485 標準的印刷油墨和黏合劑製作體外診斷試劑容器標籤，以提高可追溯性並防止交叉污染
  • 模組化實驗室晶片封裝形式的成長，使得快速客製化和可擴展性成為可能，從而滿足新興感染疾病診斷的需求。

第6章美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 體外診斷包裝市場：依包裝形式分類

  • 吹塑-灌裝-密封
    • 安瓿
    • 墨水匣和磁帶
  • 軟包裝
    • 薄膜和層壓材料
    • 小袋和包裝袋
  • 硬包裝
    • 微孔盤和玻片
    • 試管和管瓶

9. 體外診斷包裝市場（依材料分類）

  • 玻璃
  • 塑膠
  • 特種聚合物
  • 永續材料

第10章 體外診斷包裝市場（依最終用戶分類）

  • 診斷實驗室
  • 醫院診所
  • 就地檢驗
  • 研究所

第11章 以滅菌狀態分類的體外診斷包裝市場

  • 非無菌
  • 無菌

12. 體外診斷包裝市場依溫度要求分類

  • 常溫
  • 冷凍
  • 冷藏

第13章 體外診斷包裝市場（依通路分類）

  • 直銷
  • 批發商
  • 線上

第14章 體外診斷包裝市場（依地區分類）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第15章 體外診斷包裝市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第16章 各國體外診斷包裝市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第17章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Amcor plc
    • Berry Global Group, Inc.
    • Gerresheimer AG
    • Stevanato Group SpA
    • West Pharmaceutical Services, Inc.
    • AptarGroup, Inc.
    • SCHOTT AG
    • Constantia Flexibles Group GmbH
    • Nelipak Corporation
    • Lohmann GmbH & Co. KG
Product Code: MRR-F6513A06BD97

The In-Vitro Diagnostics Packaging Market is projected to grow by USD 13.25 billion at a CAGR of 7.01% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 7.70 billion
Estimated Year [2025] USD 8.24 billion
Forecast Year [2032] USD 13.25 billion
CAGR (%) 7.01%

A strategic orientation toward integrity, traceability, and sustainability is reshaping how diagnostic packaging supports clinical workflows and regulatory expectations

The in-vitro diagnostics packaging landscape stands at a pivotal juncture driven by accelerating innovation, heightened regulatory scrutiny, and an intensified emphasis on supply chain resilience. Packaging functions no longer serve solely as containment and protection; they underpin diagnostic accuracy, biosafety, and traceability across the specimen lifecycle. As laboratories, hospitals, point-of-care providers, and research institutions expand testing modalities, the demand profile for packaging solutions has diversified rapidly. This transformation compels manufacturers and procurement teams to rethink material choices, aseptic processing, and end-to-end cold chain capabilities to maintain sample integrity and ensure patient safety.

Concurrently, sustainability ambitions and circular-economy objectives are influencing material selection and end-of-life considerations. Advances in specialty polymers and recyclable substrates are converging with legacy materials like glass and traditional plastics, prompting stakeholders to weigh performance against environmental impact. Regulatory authorities are also refining expectations for sterility validation and labeling, which further elevates the role of packaging as a compliance instrument. The combined effect of these forces requires cross-functional collaboration between packaging engineers, quality and regulatory teams, and commercial stakeholders to create robust, scalable solutions that meet clinical and operational realities.

Integrated manufacturing, advanced materials, and digital traceability are converging to redefine packaging's role in diagnostic accuracy, logistics, and procurement channels

The sector is experiencing transformative shifts that reconfigure competitive dynamics and operational priorities. Advances in aseptic processing technologies such as blow-fill-seal systems and integrated cartridge production are enabling higher throughput with reduced contamination risk, while flexible packaging innovations are optimizing transport weight and storage efficiency. These process-level innovations are complemented by materials science breakthroughs: specialty polymers and formulation-stable laminates are improving barrier properties and thermal tolerance, enabling expanded use cases across ambient, refrigerated, and frozen temperature requirements. As a result, packaging is evolving from passive protection to an active enabler of diagnostic performance and logistics efficiency.

Market participants are also adapting to an omnichannel procurement environment. Direct sales relationships coexist with distributor networks and online platforms, reshaping go-to-market strategies and customer engagement models. This shift drives demand for standardized technical dossiers and digital assets that support remote evaluation and qualification. Additionally, digital traceability systems and serialization are becoming expected features for high-value or regulated diagnostic shipments, creating new interoperability challenges and data governance obligations. Together, these shifts demand integrated roadmaps that align manufacturing capability, materials sourcing, and digital infrastructure to preserve product quality while improving cost and time efficiencies.

Tariff adjustments and trade policy changes have catalyzed supply chain realignment and regional production investments to protect diagnostic packaging continuity and compliance

The imposition of tariffs and trade policy adjustments in the United States during 2025 has exerted measurable pressure across inbound raw materials and finished diagnostic packaging imports, prompting rapid strategic responses from manufacturers and buyers alike. Tariff-driven cost escalation accelerated the reassessment of supplier footprints and contractual terms, particularly for components and substrates sourced from global supply nodes. This environment has increased the urgency for supply chain mapping, supplier risk assessments, and the identification of alternative raw material options that maintain barrier performance and sterility assurance without compromising regulatory compliance.

In response, many organizations have pursued nearshoring or dual-sourcing strategies to mitigate exposure to tariff volatility and cross-border customs delays. These moves often entail capital investment in regional aseptic filling and packaging capabilities, as well as renegotiation of logistics arrangements to preserve cold-chain integrity for refrigerated and frozen shipments. Price pressures have driven tighter inventory management, a shift toward longer-term supplier agreements with tariff pass-through clauses, and the acceleration of supplier qualification processes to shorten lead times. Policymakers' actions also incentivized collaboration between industry and regulators to clarify classification, harmonize certification requirements, and expedite customs processes for critical diagnostic supplies, which has reduced clearance uncertainty even as duty costs remain a factor in procurement decisions.

Granular segmentation across format, material, end-user, sterility, temperature, and distribution reveals targeted product and go-to-market imperatives for diagnostic packaging

Segmentation reveals differentiated demand patterns and technical requirements that inform product development and commercialization strategies. Packaging format dynamics show that blow-fill-seal solutions, particularly ampoules and cartridges & cassettes, are favored where sterility, precision dosing, and integrated filling are critical, while flexible packaging such as film & laminates and pouches & bags supports high-volume reagent distribution and lightweight transport. Rigid packaging categories, encompassing microplates & slides and tubes & vials, remain central to laboratory automation and sample storage, with ongoing optimization for ergonomic handling and instrument compatibility.

Material selection strongly shapes performance and environmental outcomes, with traditional glass persisting in high-purity applications while plastics deliver impact resistance and design flexibility. Specialty polymers have emerged to fulfill demanding barrier and thermal profiles, and sustainable materials are increasingly incorporated to address end-of-life and procurement sustainability mandates. End users drive divergent packaging requirements: diagnostic laboratories prioritize automation compatibility and throughput; hospitals and clinics value sterility, clinician usability, and storage efficiency; point-of-care testing demands compact, robust, and easy-to-use formats; research institutes seek customizable formats for experimental workflows. Sterility requirements bifurcate solutions between sterile and non-sterile applications, each with distinct validation and handling workflows. Temperature requirements create separate value chains for ambient, frozen, and refrigerated shipments, influencing material choices and secondary packaging. Finally, distribution channels-direct sales, distributors, and online-shape customer experience, qualification timelines, and aftermarket support, necessitating tailored service and technical documentation for each route to market.

Regional differences in regulatory priorities, manufacturing capacity, and cold chain maturity are shaping divergent strategic approaches to diagnostic packaging deployment

Regional dynamics underscore heterogeneous priorities that influence manufacturing footprint, regulatory strategies, and logistics investment. In the Americas, demand concentrates on advanced laboratory infrastructure and point-of-care rollout, creating robust uptake for sterile, automation-ready rigid formats and a sustained need for refrigerated and ambient solutions. The region's regulatory landscape and procurement cycles encourage investments in domestic or nearshore production, particularly where policy shifts increase the cost of imports or prioritize supply security.

Europe, the Middle East and Africa present a mosaic of regulatory stringency and sustainability focus. Western European markets emphasize material recyclability, extended producer responsibility, and tight sterility controls, which in turn accelerate adoption of specialty polymers and validated sterilization pathways. In EMEA markets where centralized lab networks coexist with decentralized testing, packaging solutions must balance cost-efficiency with traceability and compatibility across diverse cold chain infrastructures. The Asia-Pacific region combines large-scale manufacturing capacity, rapidly expanding diagnostic access, and divergent logistics maturity. Strong production clusters in the region enable competitive sourcing of both glass and polymer formats, but heterogeneity in cold chain and regulatory harmonization requires localized validation strategies and adaptable packaging designs to meet varied end-user needs.

Companies are reinforcing aseptic capability, materials innovation, and digital traceability while expanding service bundles and regional production to secure competitive advantage

Leading companies in the diagnostic packaging space are pursuing an array of competitive strategies that combine technological investment with commercial realignment. Many are deepening capabilities in aseptic processing and blow-fill-seal systems to reduce contamination risk and accelerate throughput for sterile single-use products. Simultaneously, materials innovation programs target specialty polymers and laminate constructions that improve barrier and thermal stability while enabling recyclability or reduced material mass. Firms are also investing in digital tools such as serialization, RFID tagging, and cloud-enabled traceability to meet customer demands for chain-of-custody visibility and compliance documentation.

Commercially, players are expanding service offerings that pair packaging with analytical support, qualification packs, and regulatory dossiers to simplify customer adoption and shorten qualification cycles. Strategic partnerships and targeted acquisitions have become common to access niche capabilities, scale manufacturing, and extend distribution networks. In parallel, quality and regulatory teams within these companies are enhancing sterility validation protocols and cold chain qualification to support refrigerated and frozen shipments, reflecting the broader market emphasis on preserving sample integrity across diverse temperature requirements. Together, these initiatives signal a surge in vertically integrated approaches that combine materials expertise, aseptic manufacturing, and aftermarket services to reinforce competitive differentiation.

Adopt integrated supply diversification, regional capacity buildouts, and digital traceability to strengthen resilience, compliance, and customer alignment in diagnostic packaging

Industry leaders can adopt a focused set of actions to convert disruption into advantage. Prioritize diversified supplier networks and dual-source critical substrates to mitigate exposure to trade policy shifts and regional production constraints while maintaining validated equivalency across materials. Invest in regional aseptic filling and secondary packaging capacity to reduce lead times and tariff exposure, and align those investments with sterility validation programs to ensure regulatory readiness. Incorporate specialty polymer options and validated laminate constructions into product portfolios to address thermal and barrier needs across ambient, refrigerated, and frozen use cases while also advancing measurable sustainability goals.

Enhance digital capabilities by deploying serialization and real-time traceability systems that integrate with customer laboratory information management systems and distribution partners. Tailor go-to-market models for different channels: strengthen direct sales engagement for strategic accounts, streamline qualification kits and technical documentation for distributors, and optimize digital assets and e-commerce capabilities for online procurement. Pair technology investments with commercial incentives such as flexible contract terms and inventory consignment models to stabilize supply for key end users like diagnostic laboratories, hospitals and clinics, point-of-care providers, and research institutes. Finally, institutionalize cross-functional decision-making processes that bring procurement, quality, regulatory, and operations together to accelerate supplier qualification, change control, and new product introductions.

A rigorous mixed-methods research approach blended stakeholder interviews, technical reviews, and cross-validated case analyses to produce actionable insights into packaging technologies and adoption

The research methodology combined primary and secondary investigative approaches to produce an evidence-based view of the diagnostic packaging landscape. Primary research incorporated structured interviews with packaging engineers, supply chain leaders, regulatory affairs specialists, and procurement heads across diagnostic laboratories, hospitals and clinics, point-of-care testing providers, and research institutes to capture operational priorities and validation practices. Secondary investigation reviewed regulatory guidances, technical standards, patent activity, manufacturing case studies, and scientific literature to triangulate material performance, aseptic processing trends, and cold chain requirements for ambient, refrigerated, and frozen shipments.

Data validation and synthesis involved cross-referencing interview insights with manufacturing and logistics case examples, ensuring that material choices and format preferences reflect real-world adoption patterns. Segment-level analysis was informed by format-specific technical comparisons-examining blow-fill-seal ampoules and cartridges & cassettes, flexible film & laminate constructions and pouches & bags, as well as rigid microplates & slides alongside tubes & vials-while mapping material properties across glass, plastic, specialty polymers, and sustainable materials. The methodology also evaluated distribution channel behaviors across direct sales, distributors, and online platforms to reflect procurement realities. Limitations include variations in regional regulations and the pace of technology adoption, which were mitigated by validating findings with multiple stakeholders and prioritizing conservative interpretation where practices diverged significantly.

Coordinated investments in aseptic processing, materials qualification, and digital traceability are critical to secure diagnostic integrity and operational resilience

The convergence of manufacturing innovation, materials science, regulatory evolution, and trade policy adjustments is setting a new operating paradigm for in-vitro diagnostics packaging. Packaging is increasingly recognized as a strategic asset that safeguards diagnostic fidelity, enables supply chain agility, and supports sustainability commitments. Organizations that align investments in aseptic capabilities, specialty materials, and digital traceability with regionally optimized manufacturing footprints will be best positioned to manage tariff-driven volatility and fulfill the nuanced needs of diagnostic laboratories, hospitals and clinics, point-of-care testers, and research institutes.

Moving forward, success will depend on the ability to execute coordinated strategies that integrate product development, regulatory planning, and commercial deployment. Stakeholders that institutionalize supplier diversification, accelerate material qualification protocols, and deploy traceability systems will reduce operational risk while improving time-to-market. In short, proactive alignment of technical capability and commercial strategy is the most reliable path to preserving sample integrity, meeting evolving regulatory demands, and capturing the strategic benefits that flow from a resilient, future-ready packaging ecosystem.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Adoption of sustainable and recyclable materials in in-vitro diagnostics packaging to meet regulatory and environmental demands
  • 5.2. Integration of smart packaging technologies like RFID and NFC for enhanced traceability and patient safety in IVD kits
  • 5.3. Development of single-use microfluidic cartridges with hermetic sealing for point-of-care in-vitro diagnostic tests
  • 5.4. Customizable cold chain packaging solutions incorporating phase change materials to preserve biomarker stability during transportation
  • 5.5. Shift towards child-resistant and tamper-evident packaging designs to ensure compliance with global safety regulations for IVD products
  • 5.6. Use of antimicrobial coatings on diagnostic device casings to reduce contamination risks and extend shelf life
  • 5.7. Implementation of digital printing and variable data printing for batch-specific labeling and real-time quality control in IVD packaging
  • 5.8. Examination of lightweight polymeric blister packs to reduce packaging weight and minimize waste in high-volume diagnostic assays
  • 5.9. Adoption of ISO 13485 compliant printing inks and adhesives to improve traceability and prevent cross contamination in IVD container labels
  • 5.10. Growth of modular lab-on-chip packaging formats enabling rapid customization and scalability for emerging infectious disease diagnostics

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. In-Vitro Diagnostics Packaging Market, by Packaging Format

  • 8.1. Blow-Fill-Seal
    • 8.1.1. Ampoules
    • 8.1.2. Cartridges & Cassettes
  • 8.2. Flexible Packaging
    • 8.2.1. Film & Laminates
    • 8.2.2. Pouches & Bags
  • 8.3. Rigid Packaging
    • 8.3.1. Microplates & Slides
    • 8.3.2. Tubes & Vials

9. In-Vitro Diagnostics Packaging Market, by Material

  • 9.1. Glass
  • 9.2. Plastic
  • 9.3. Specialty Polymers
  • 9.4. Sustainable Materials

10. In-Vitro Diagnostics Packaging Market, by End User

  • 10.1. Diagnostic Laboratories
  • 10.2. Hospitals & Clinics
  • 10.3. Point-Of-Care Testing
  • 10.4. Research Institutes

11. In-Vitro Diagnostics Packaging Market, by Sterility

  • 11.1. Non-Sterile
  • 11.2. Sterile

12. In-Vitro Diagnostics Packaging Market, by Temperature Requirement

  • 12.1. Ambient
  • 12.2. Frozen
  • 12.3. Refrigerated

13. In-Vitro Diagnostics Packaging Market, by Distribution Channel

  • 13.1. Direct Sales
  • 13.2. Distributors
  • 13.3. Online

14. In-Vitro Diagnostics Packaging Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. In-Vitro Diagnostics Packaging Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. In-Vitro Diagnostics Packaging Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. Competitive Landscape

  • 17.1. Market Share Analysis, 2024
  • 17.2. FPNV Positioning Matrix, 2024
  • 17.3. Competitive Analysis
    • 17.3.1. Amcor plc
    • 17.3.2. Berry Global Group, Inc.
    • 17.3.3. Gerresheimer AG
    • 17.3.4. Stevanato Group S.p.A.
    • 17.3.5. West Pharmaceutical Services, Inc.
    • 17.3.6. AptarGroup, Inc.
    • 17.3.7. SCHOTT AG
    • 17.3.8. Constantia Flexibles Group GmbH
    • 17.3.9. Nelipak Corporation
    • 17.3.10. Lohmann GmbH & Co. KG

LIST OF FIGURES

  • FIGURE 1. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PACKAGING FORMAT, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PACKAGING FORMAT, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY MATERIAL, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY MATERIAL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY STERILITY, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY STERILITY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 13. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. AMERICAS IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. NORTH AMERICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. LATIN AMERICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. EUROPE IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. MIDDLE EAST IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. AFRICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. ASEAN IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. GCC IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. EUROPEAN UNION IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. BRICS IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. G7 IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. NATO IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 30. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 31. IN-VITRO DIAGNOSTICS PACKAGING MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 32. IN-VITRO DIAGNOSTICS PACKAGING MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. IN-VITRO DIAGNOSTICS PACKAGING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PACKAGING FORMAT, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PACKAGING FORMAT, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY BLOW-FILL-SEAL, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY BLOW-FILL-SEAL, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY BLOW-FILL-SEAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY BLOW-FILL-SEAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY BLOW-FILL-SEAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY BLOW-FILL-SEAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY BLOW-FILL-SEAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY BLOW-FILL-SEAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY AMPOULES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY AMPOULES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY AMPOULES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY AMPOULES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY AMPOULES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY AMPOULES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY CARTRIDGES & CASSETTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY CARTRIDGES & CASSETTES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY CARTRIDGES & CASSETTES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY CARTRIDGES & CASSETTES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY CARTRIDGES & CASSETTES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY CARTRIDGES & CASSETTES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY FLEXIBLE PACKAGING, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY FLEXIBLE PACKAGING, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY FLEXIBLE PACKAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY FLEXIBLE PACKAGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY FLEXIBLE PACKAGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY FLEXIBLE PACKAGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY FLEXIBLE PACKAGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY FLEXIBLE PACKAGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY FILM & LAMINATES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY FILM & LAMINATES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY FILM & LAMINATES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY FILM & LAMINATES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY FILM & LAMINATES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY FILM & LAMINATES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY POUCHES & BAGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY POUCHES & BAGS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY POUCHES & BAGS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY POUCHES & BAGS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY POUCHES & BAGS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY POUCHES & BAGS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY RIGID PACKAGING, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY RIGID PACKAGING, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY RIGID PACKAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY RIGID PACKAGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY RIGID PACKAGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY RIGID PACKAGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY RIGID PACKAGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY RIGID PACKAGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY MICROPLATES & SLIDES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY MICROPLATES & SLIDES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY MICROPLATES & SLIDES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY MICROPLATES & SLIDES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY MICROPLATES & SLIDES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY MICROPLATES & SLIDES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY TUBES & VIALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY TUBES & VIALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY TUBES & VIALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY TUBES & VIALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY TUBES & VIALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY TUBES & VIALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY GLASS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY GLASS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY GLASS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY GLASS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY GLASS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY GLASS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PLASTIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PLASTIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PLASTIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PLASTIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PLASTIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PLASTIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY SPECIALTY POLYMERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY SPECIALTY POLYMERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY SPECIALTY POLYMERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY SPECIALTY POLYMERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY SPECIALTY POLYMERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY SPECIALTY POLYMERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY SUSTAINABLE MATERIALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY SUSTAINABLE MATERIALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY SUSTAINABLE MATERIALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY SUSTAINABLE MATERIALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY SUSTAINABLE MATERIALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY SUSTAINABLE MATERIALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY POINT-OF-CARE TESTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY POINT-OF-CARE TESTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY POINT-OF-CARE TESTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY POINT-OF-CARE TESTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY POINT-OF-CARE TESTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY POINT-OF-CARE TESTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY STERILITY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY STERILITY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY NON-STERILE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY NON-STERILE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY NON-STERILE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY NON-STERILE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY NON-STERILE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY NON-STERILE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY STERILE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY STERILE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY STERILE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY STERILE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY STERILE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY STERILE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY AMBIENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY AMBIENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY AMBIENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY AMBIENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY AMBIENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY AMBIENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY FROZEN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY FROZEN, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY FROZEN, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY FROZEN, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY FROZEN, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY FROZEN, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY REFRIGERATED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY REFRIGERATED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY REFRIGERATED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY REFRIGERATED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY REFRIGERATED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY REFRIGERATED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY DIRECT SALES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY ONLINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY ONLINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY ONLINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY ONLINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY ONLINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 175. AMERICAS IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 176. AMERICAS IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 177. AMERICAS IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PACKAGING FORMAT, 2018-2024 (USD MILLION)
  • TABLE 178. AMERICAS IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PACKAGING FORMAT, 2025-2032 (USD MILLION)
  • TABLE 179. AMERICAS IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY BLOW-FILL-SEAL, 2018-2024 (USD MILLION)
  • TABLE 180. AMERICAS IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY BLOW-FILL-SEAL, 2025-2032 (USD MILLION)
  • TABLE 181. AMERICAS IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY FLEXIBLE PACKAGING, 2018-2024 (USD MILLION)
  • TABLE 182. AMERICAS IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY FLEXIBLE PACKAGING, 2025-2032 (USD MILLION)
  • TABLE 183. AMERICAS IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY RIGID PACKAGING, 2018-2024 (USD MILLION)
  • TABLE 184. AMERICAS IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY RIGID PACKAGING, 2025-2032 (USD MILLION)
  • TABLE 185. AMERICAS IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 186. AMERICAS IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 187. AMERICAS IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 188. AMERICAS IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 189. AMERICAS IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY STERILITY, 2018-2024 (USD MILLION)
  • TABLE 190. AMERICAS IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY STERILITY, 2025-2032 (USD MILLION)
  • TABLE 191. AMERICAS IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2018-2024 (USD MILLION)
  • TABLE 192. AMERICAS IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2025-2032 (USD MILLION)
  • TABLE 193. AMERICAS IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 194. AMERICAS IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 195. NORTH AMERICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 196. NORTH AMERICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 197. NORTH AMERICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PACKAGING FORMAT, 2018-2024 (USD MILLION)
  • TABLE 198. NORTH AMERICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PACKAGING FORMAT, 2025-2032 (USD MILLION)
  • TABLE 199. NORTH AMERICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY BLOW-FILL-SEAL, 2018-2024 (USD MILLION)
  • TABLE 200. NORTH AMERICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY BLOW-FILL-SEAL, 2025-2032 (USD MILLION)
  • TABLE 201. NORTH AMERICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY FLEXIBLE PACKAGING, 2018-2024 (USD MILLION)
  • TABLE 202. NORTH AMERICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY FLEXIBLE PACKAGING, 2025-2032 (USD MILLION)
  • TABLE 203. NORTH AMERICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY RIGID PACKAGING, 2018-2024 (USD MILLION)
  • TABLE 204. NORTH AMERICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY RIGID PACKAGING, 2025-2032 (USD MILLION)
  • TABLE 205. NORTH AMERICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 206. NORTH AMERICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 207. NORTH AMERICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 208. NORTH AMERICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 209. NORTH AMERICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY STERILITY, 2018-2024 (USD MILLION)
  • TABLE 210. NORTH AMERICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY STERILITY, 2025-2032 (USD MILLION)
  • TABLE 211. NORTH AMERICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2018-2024 (USD MILLION)
  • TABLE 212. NORTH AMERICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2025-2032 (USD MILLION)
  • TABLE 213. NORTH AMERICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 214. NORTH AMERICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 215. LATIN AMERICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 216. LATIN AMERICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 217. LATIN AMERICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PACKAGING FORMAT, 2018-2024 (USD MILLION)
  • TABLE 218. LATIN AMERICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PACKAGING FORMAT, 2025-2032 (USD MILLION)
  • TABLE 219. LATIN AMERICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY BLOW-FILL-SEAL, 2018-2024 (USD MILLION)
  • TABLE 220. LATIN AMERICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY BLOW-FILL-SEAL, 2025-2032 (USD MILLION)
  • TABLE 221. LATIN AMERICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY FLEXIBLE PACKAGING, 2018-2024 (USD MILLION)
  • TABLE 222. LATIN AMERICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY FLEXIBLE PACKAGING, 2025-2032 (USD MILLION)
  • TABLE 223. LATIN AMERICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY RIGID PACKAGING, 2018-2024 (USD MILLION)
  • TABLE 224. LATIN AMERICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY RIGID PACKAGING, 2025-2032 (USD MILLION)
  • TABLE 225. LATIN AMERICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 226. LATIN AMERICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 227. LATIN AMERICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 228. LATIN AMERICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 229. LATIN AMERICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY STERILITY, 2018-2024 (USD MILLION)
  • TABLE 230. LATIN AMERICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY STERILITY, 2025-2032 (USD MILLION)
  • TABLE 231. LATIN AMERICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2018-2024 (USD MILLION)
  • TABLE 232. LATIN AMERICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2025-2032 (USD MILLION)
  • TABLE 233. LATIN AMERICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 234. LATIN AMERICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 235. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 236. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 237. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PACKAGING FORMAT, 2018-2024 (USD MILLION)
  • TABLE 238. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PACKAGING FORMAT, 2025-2032 (USD MILLION)
  • TABLE 239. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY BLOW-FILL-SEAL, 2018-2024 (USD MILLION)
  • TABLE 240. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY BLOW-FILL-SEAL, 2025-2032 (USD MILLION)
  • TABLE 241. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY FLEXIBLE PACKAGING, 2018-2024 (USD MILLION)
  • TABLE 242. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY FLEXIBLE PACKAGING, 2025-2032 (USD MILLION)
  • TABLE 243. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY RIGID PACKAGING, 2018-2024 (USD MILLION)
  • TABLE 244. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY RIGID PACKAGING, 2025-2032 (USD MILLION)
  • TABLE 245. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 246. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 247. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 248. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 249. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY STERILITY, 2018-2024 (USD MILLION)
  • TABLE 250. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY STERILITY, 2025-2032 (USD MILLION)
  • TABLE 251. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2018-2024 (USD MILLION)
  • TABLE 252. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2025-2032 (USD MILLION)
  • TABLE 253. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 254. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 255. EUROPE IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 256. EUROPE IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 257. EUROPE IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PACKAGING FORMAT, 2018-2024 (USD MILLION)
  • TABLE 258. EUROPE IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PACKAGING FORMAT, 2025-2032 (USD MILLION)
  • TABLE 259. EUROPE IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY BLOW-FILL-SEAL, 2018-2024 (USD MILLION)
  • TABLE 260. EUROPE IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY BLOW-FILL-SEAL, 2025-2032 (USD MILLION)
  • TABLE 261. EUROPE IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY FLEXIBLE PACKAGING, 2018-2024 (USD MILLION)
  • TABLE 262. EUROPE IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY FLEXIBLE PACKAGING, 2025-2032 (USD MILLION)
  • TABLE 263. EUROPE IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY RIGID PACKAGING, 2018-2024 (USD MILLION)
  • TABLE 264. EUROPE IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY RIGID PACKAGING, 2025-2032 (USD MILLION)
  • TABLE 265. EUROPE IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 266. EUROPE IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 267. EUROPE IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 268. EUROPE IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 269. EUROPE IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY STERILITY, 2018-2024 (USD MILLION)
  • TABLE 270. EUROPE IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY STERILITY, 2025-2032 (USD MILLION)
  • TABLE 271. EUROPE IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2018-2024 (USD MILLION)
  • TABLE 272. EUROPE IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2025-2032 (USD MILLION)
  • TABLE 273. EUROPE IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 274. EUROPE IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 275. MIDDLE EAST IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 276. MIDDLE EAST IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 277. MIDDLE EAST IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PACKAGING FORMAT, 2018-2024 (USD MILLION)
  • TABLE 278. MIDDLE EAST IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PACKAGING FORMAT, 2025-2032 (USD MILLION)
  • TABLE 279. MIDDLE EAST IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY BLOW-FILL-SEAL, 2018-2024 (USD MILLION)
  • TABLE 280. MIDDLE EAST IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY BLOW-FILL-SEAL, 2025-2032 (USD MILLION)
  • TABLE 281. MIDDLE EAST IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY FLEXIBLE PACKAGING, 2018-2024 (USD MILLION)
  • TABLE 282. MIDDLE EAST IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY FLEXIBLE PACKAGING, 2025-2032 (USD MILLION)
  • TABLE 283. MIDDLE EAST IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY RIGID PACKAGING, 2018-2024 (USD MILLION)
  • TABLE 284. MIDDLE EAST IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY RIGID PACKAGING, 2025-2032 (USD MILLION)
  • TABLE 285. MIDDLE EAST IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 286. MIDDLE EAST IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 287. MIDDLE EAST IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 288. MIDDLE EAST IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 289. MIDDLE EAST IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY STERILITY, 2018-2024 (USD MILLION)
  • TABLE 290. MIDDLE EAST IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY STERILITY, 2025-2032 (USD MILLION)
  • TABLE 291. MIDDLE EAST IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY TEMPERATURE REQUIREMENT, 2018-2024 (USD MILLION)

TABLE 29